Obesity and alzheimer?s disease: A link between body weight and cognitive function in old age

American Journal of Alzheimer's Disease and other Dementias

Volumn 24, Issue 6, 2009, Pages 445-449

  Naderali, Ebrahim K ^a,b   Ratcliffe, Stuart H ^b   Dale, Mark C ^b  

^a LIVERPOOL HOPE UNIVERSITY   (United Kingdom)

^b MAC UK Neuroscience Ltd   (United Kingdom)

Author keywords

Alzheimer?s disease; Cognitive function; Obesity; Old age

Indexed keywords

ALZHEIMER DISEASE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR MALFORMATION; CARDIOVASCULAR RISK; COGNITION; DIABETES MELLITUS; DISEASE ASSOCIATION; GLUCOSE TRANSPORT; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INSULIN METABOLISM; INSULIN RESISTANCE; MORBIDITY; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; REVIEW; SENESCENCE;

EID: 70450255115     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317509348208     Document Type: Review

References (31)

1. Wing RR, Mathews KA, Kuller LH, Meilahn EN, Plantinga P. Waist to hip ratio in middle-aged women. Associations with behavioral and psychological factors and with changes in cardiovascular risk factors. Arterioscler Thromb. 1991 ; 11 (5). 1250-1257.
2. Wellman NS, Friedberg B. Causes and consequences of adult obesity: health, social and economic impacts in the United States. Asia Pac J Clin Nutr. 2002 ; 11 (suppl 8). S705 - S709.
3. Law CM, Shiell AW, Newsome CA, et al. Fetal, infant and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation. 2002 ; 105 (9). 1088-1092.
4. Lloyd LJ, Langley-Evans SC, McMullen S. Childhood obesity and adult cardiovascular disease risk: a systematic review. Int J Obes. (Lond). 2009May 12. [Epub ahead of print].
5. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997 ; 337 (13). 869-873.
6. Duflou J., Virmani R., Robin I., Burke A., Farb A., Smialek J. Sudden death as a result of heart disease in morbid obesity. Am J Heart. 1995 ; 130 (2). 306-313.
7. Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990 ; 86 (1). 228-234.
8. Fatani S., Pickavance LC, Sadler CJ, et al. Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study. Nutr Metab. (Lond). 2007 ; 4: 15.
9. Naderali EK, Fatani S. The effects of fenofibrate on metabolic and vascular changes induced by chocolate-supplemented diet in the rat. Eur J Pharmacol. 2005 ; 521 (1-3). 99-104.
10. Steinberg HO, Chacker H., Leaming R., Johnson A., Brechtel G., Baron AD Obesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance. J Clin Invest. 1996 ; 97 (11). 2601-2610.
11. Watson GS, Craft S. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer?s disease. Eur J Pharmacol. 2004 ; 490 (1-3). 97-113.
12. Watson GS, Craft S. The role of insulin resistance in the pathogenesis of Alzheimer?s disease: implications for treatment. CNS Drugs. 2003 ; 17 (1). 27-45.
13. Marks DR, Tucker K., Cavallin MA, Mast TG, Fadool DA Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci. 2009 ; 29 (20). 6734-6751.
14. Selkoe DJ The genetics and molecular pathology of Alzheimer?s disease: roles of amyloid and the presenilins. Neurol Clin. 2000 ; 18 (4). 903-922.
15. Jellinger KA, Attems J. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol. 2007 ; 113 (2). 107-117.
16. Premkumar DR, Cohen DL, Hedera P., Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer?s disease. Am J Pathol. 1996 ; 148 (6). 2083-2095.
17. Profenno LA, Faraone SV Diabetes and overweight associate with non-APOE4 genotype in an Alzheimer?s disease population. Am J Med Genet B Neuropsychiatr Genet. 2008 ; 147B (6). 822-829.
18. Lafortuna CL, Agosti F., Proietti M., Adorni F., Sartorio A. The combined effect of adiposity, fat distribution and age on cardiovascular risk factors and motor disability in a cohort of obese women (aged 18-83). J Endocrinol Invest. 2006 ; 29 (10). 905-912.
19. Elias MF, Elias PK, Sullivan LM, Wolf PA, D'Agostino RB Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003 ; 27 (2). 260-268.
20. Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009 ; 66 (3). 336-342.
21. Hughes TF, Borenstein AR, Schofield E., Wu Y., Larson EB Association between late-life body mass index and dementia: the Kame Project. Neurology. 2009 ; 72 (20). 1741-1746.
22. Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J., Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007 ; 4 (2). 103-109.
23. Gunstad J., Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry. 2007 ; 48 (1). 57-61.
24. Gustafson D., Rothenberg E., Blennow K., Steen B., Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003 ; 163 (13). 1524-1528.
25. Gazdzinski S., Kornak J., Weiner MW, Meyerhoff DJ Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol. 2008 ; 63 (5). 652-657.
26. Gunstad J., Spitznagel MB, Glickman E., et al. beta-Amyloid is associated with reduced cognitive function in healthy older adults. J Neuropsychiatry Clin Neurosci. 2008 ; 20 (3). 327-330.
27. Leahey TM, Myers TA, Gunstad J., et al. Abeta40 is associated with cognitive function, body fat and physical fitness in healthy older adults. Nutr Neurosci. 2007 ; 10 (5-6). 205-209.
28. Mrak RE Alzheimer-type neuropathological changes in morbidly obese elderly individuals. Clin Neuropathol. 2009 ; 28 (1). 40-45.
29. Moroz N., Tong M., Longato L., Xu H., de la Monte SM Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis. 2008 ; 15 (1). 29-44.
30. Gustafson D., Lissner L., Bengtsson C., Bjrkelund C., Skoog I. A 24-year follow-up of body mass index and cerebral atrophy. Neurology. 2004 ; 63 (10). 1876-1881.
31. Cao D., Lu H., Lewis TL, Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem. 2007 ; 282 (50). 36275-36282.